Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Claude Cormier who wrote (48833)	2/17/2019 6:11:25 PM
From: russet	1 Recommendation Recommended By Cogito Ergo Sum Read Replies (2) \| Respond to of 49402

I am saying that chemists are making many of the biologically active components such as THC, CBD and many of the other 120 biologically active components of the plant from simple chemical compounds. They don't need to grow the plant or extract the chemicals from the plant. They make them in a lab. Many private labs and university labs as well as some publicly traded companies such as CRDL. CRDL is making synthetic CBD right now and is looking to sell to pharmacies and suppliers in Canada this year. Also some labs are cloning the weed plant genes in various ways to develop biological factories producing all the 120 active identified biologically active components. They grow these in culture, without the need to grow the plant and deal with the leaves, stem etc. This is disruptive technology that could transform everything in a few years.